本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nuvation Bio, Inc.

4.38
+0.10002.34%
盘后4.390.0107+0.24%16:20 EDT
成交量:253.56万
成交额:1,116.16万
市值:15.22亿
市盈率:-7.30
高:4.47
开:4.41
低:4.37
收:4.28
52周最高:9.75
52周最低:1.54
股本:3.48亿
流通股本:2.31亿
量比:0.61
换手率:1.10%
股息:- -
股息率:- -
每股收益(TTM):-0.6000
每股收益(LYR):-0.6000
净资产收益率:-53.18%
总资产收益率:-23.46%
市净率:4.98
市盈率(LYR):-7.30

数据加载中...

2026/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/10

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

重要事件披露

Form 8-K - Current report
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

重要事件披露

Form 8-K - Current report
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]